clariscan
eldan electronic instruments co ltd, israel - gadoteric acid - solution for injection - gadoteric acid 279.3 mg / 1 ml - gadoteric acid - enhancement of contrast in magnetic resonance imaging.aencephalic and spinal pathologies: brain tumours, tumours of the spine and the surrounding tissue, intervertebral disk prolapse infectious diseases.abdominal pathologies: primary and secondary liver tumours.osteo-articular pathology: bone and soft tissue tumours synovial diseases.magnetic resonance imaging for angiography.
metastron
eldan electronic instruments co ltd - strontium (89sr) chloride - solution for injection - strontium (89sr) chloride 150 mbq / 4 ml - strontium (89sr) chloride - strontium (89sr) chloride - adjunct and alternative to external beam radiotherapy for palliation of pain from bone metastases secondary to prostatic carcinoma at the stage of hormone therapy failure.
dextrose vioser solution for infusion 5 %
eldan electronic instruments co ltd, israel - dextrose anhydrous - solution for infusion - dextrose anhydrous 5 % - vehicle solution for supplementary medication. energy supply, hypertonic dehydration
datscan 74 mbqml
eldan electronic instruments co ltd - ioflupane - solution for injection - ioflupane 74 mbq/ml - iodine ioflupane (123i) - other dopaminergic agents - datscan is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum: - in adult patients with clinically uncertain parkinsonian syndromes, for example those with early symptoms, in order to help differentiate essential tremor from parkinsonian syndromes related to idiopathic parkinson's disease multiple system atrophy and progressive supranuclear palsy. - datscan is unable to discriminate between parkinson's disease multiple system atrophy and progressive supranuclear palsy. - in adult patients to help differentiate probable dementia with lewy bodies from alzheimer's disease. datscan is unable to discriminate between dementia with lewy bodies and parkinson's disease dementia
myoview
eldan electronic instruments co ltd - tetrofosmin - lyophilized powder for solution for injection - tetrofosmin 0.23 mg/vial - technetium (99mtc) tetrofosmin - indicated as an adjunct in the diagnosis and localization of myocardial ischaemia or infarction. myoview is indicated as an adjunct to the initial assessments (e.g. palpation mammography or alternative imaging modalities and/or cytology) in characterisation of malignancy of suspected breast lesions where all these other recommended tests were inconclusive.
myoview
eldan electronic instruments co ltd, israel - tetrofosmin - lyophilized powder for injection - tetrofosmin 0.23 mg/vial - indicated as an adjunct in the diagnosis and localization of myocardial ischaemia or infarction. myoview is indicated as an adjunct to the initial assessments (e.g. palpation mammography or alternative imaging modalities and/or cytology) in characterisation of malignancy of suspected breast lesions where all these other recommended tests were inconclusive.
sodium chloride vioser solution 0.9 %
eldan electronic instruments co ltd, israel - sodium chloride - solution - sodium chloride 9 mg/ml - sodium chloride - short- term intravascular volume substitution. hypotonic dehydration or isotonic dehydration. vehicle solution for supplementary medication.flued and electrolyte replacement, hypochloremic alkalosis and chloride losses.externally for wound irrigation and moistening of wound tamponades dressing
ringer lactated solutionvioser
eldan electronic instruments co ltd, israel - calcium chloride dihydrate; potassium chloride; sodium chloride; sodium lactate - solution for infusion - sodium lactate 3.14 g/l; calcium chloride dihydrate 0.26 g/l; potassium chloride 0.41 g/l; sodium chloride 6.02 g/l - electrolytes - source of water and electrolytes. regulation or maintenance of metabolic acidosis (except lactic acidosis)
mannitolvioser solution for infusion 20 %
eldan electronic instruments co ltd, israel - mannitol - solution for infusion - mannitol 200 mg/ml - mannitol - mannitol 20%, solution for infusion is indicated for: - the promotion of diuresis, in the prevention and/or treatment of the oliguric phase of acute renal failure before irreversible renal failure becomes established; - the reduction of intracranial pressure and treatment of cerebral edema by reducing brain mass; - the reduction of elevated intraocular pressure when the pressure cannot be lowered by other means, and promoting the urinary excretion of toxic substances
ceretec
eldan electronic instruments co ltd - exametazime - powder for solution for injection - exametazime 0.5 mg/vial - regional cerebral blood flow scintigraphy- leucocytes labelling.